Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Shortage reports
Actual shortage:
12 (9%)
Anticipated shortage:
0 (0%)
Avoided shortage:
5 (4%)
Resolved:
111 (87%)
128
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
2 (67%)
Reversed:
1 (33%)
3
17 (13%)
1 (8%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| XYLAC | 10MG | TABLET | Resolved | 2024-04-29 | 2024-11-14 | 226445 |
| XYLAC | 25MG | TABLET | Avoided shortage | 2017-07-26 | 2017-10-05 | 17288 |
| XYLAC | 25MG | TABLET | Resolved | 2024-03-19 | 2024-11-14 | 222737 |
| XYLAC | 50MG | TABLET | Actual shortage | 2017-04-04 | 2018-12-22 | 5448 |
| XYLAC | 2.5MG | TABLET | Resolved | 2017-06-12 | 2017-10-05 | 12630 |
| XYLAC | 2.5MG | TABLET | Resolved | 2017-08-15 | 2017-10-05 | 19370 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-02-22 | 2024-05-10 | 220293 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-07-11 | 2024-09-23 | 232696 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBAVYR | 400MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182029 |
| IBAVYR | 200MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182060 |
| OCPHYL | 500MCG | SOLUTION | Reversed | 2017-04-10 | 2017-04-10 | 6237 |
Showing 1 to 3 of 3